Clinical Genetics · Miami, FL
NPI
1578520250
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1601 NW 12 Ave, M851
Miami, FL, 33101
Phone (305) 243-4029
Groups this clinician bills Medicare through
Medicare paid, 2023
$2,805
21 services
Medicare patients, 2023
18
Average age 63
Drug cost, 2024
$1.6M
53 prescriptions
Company payments, 2025
$12K
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Deborah S Barbouth prescribed most often to Medicare patients was Cerdelga (Eliglustat Tartrate), with 26 prescriptions and refills. In total Deborah S Barbouth wrote 53 Medicare prescriptions that cost $1.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Cerdelga Eliglustat Tartrate | 26 | 26 | Under 11 | $764K |
| Ravicti Glycerol Phenylbutyrate | 13 | 13 | Under 11 | $679K |
| Sapropterin Dihydrochloride Generic | 13 | 13 | Under 11 | $170K |
Brand drugs: 39 claims; generic drugs: 14 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deborah S Barbouth $12K ($12K in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $10K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.